Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

We performed a national population-based study of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) in Sweden in 2007–2014 to assess treatment intent and risk of relapsed/refractory disease, including central nervous system (CNS) relapse, in the presence of competing risks. Overall,...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrysson, Sara, Eloranta, Sandra, Ekberg, Sara, Enblad, Gunilla, Jerkeman, Mats, Wahlin, Bjorn E., Andersson, Per-Ola, Smedby, Karin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791057/
https://www.ncbi.nlm.nih.gov/pubmed/33414443
http://dx.doi.org/10.1038/s41408-020-00403-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791057/
https://www.ncbi.nlm.nih.gov/pubmed/33414443
http://dx.doi.org/10.1038/s41408-020-00403-1

Ejemplares similares